Torrent Pharmaceuticals Limited

NSEI:TORNTPHARM 株式レポート

時価総額:₹976.9b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

Torrent Pharmaceuticals 配当金

配当金 基準チェック /46

Torrent Pharmaceuticals配当を支払う会社であり、現在の利回りは0.97%で、収益によって十分にカバーされています。

主要情報

1.0%

配当利回り

57%

配当性向

業界平均利回り0.8%
次回配当支払日n/a
配当落ち日21 Jun 24
一株当たり配当金n/a
一株当たり利益₹48.93
3年後の配当利回り予想1.2%

最近の配当金アップデート

Torrent Pharmaceuticals (NSE:TORNTPHARM) Is Increasing Its Dividend To ₹22.00

Feb 05
Torrent Pharmaceuticals (NSE:TORNTPHARM) Is Increasing Its Dividend To ₹22.00

Recent updates

Torrent Pharmaceuticals Limited's (NSE:TORNTPHARM) P/E Is On The Mark

Apr 16
Torrent Pharmaceuticals Limited's (NSE:TORNTPHARM) P/E Is On The Mark

Does Torrent Pharmaceuticals (NSE:TORNTPHARM) Have A Healthy Balance Sheet?

Mar 03
Does Torrent Pharmaceuticals (NSE:TORNTPHARM) Have A Healthy Balance Sheet?

Torrent Pharmaceuticals (NSE:TORNTPHARM) Is Increasing Its Dividend To ₹22.00

Feb 05
Torrent Pharmaceuticals (NSE:TORNTPHARM) Is Increasing Its Dividend To ₹22.00

Investors Interested In Torrent Pharmaceuticals Limited's (NSE:TORNTPHARM) Earnings

Jan 07
Investors Interested In Torrent Pharmaceuticals Limited's (NSE:TORNTPHARM) Earnings

Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Rather Sparingly

Nov 14
Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Rather Sparingly

Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly

Jun 01
Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly

Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly

Mar 01
Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly

Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly

Jul 25
Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly

Torrent Pharmaceuticals' (NSE:TORNTPHARM) Soft Earnings Don't Show The Whole Picture

Jun 02
Torrent Pharmaceuticals' (NSE:TORNTPHARM) Soft Earnings Don't Show The Whole Picture

Estimating The Fair Value Of Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)

May 25
Estimating The Fair Value Of Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)

A Look At The Intrinsic Value Of Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)

Feb 18
A Look At The Intrinsic Value Of Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)

Torrent Pharmaceuticals (NSE:TORNTPHARM) Is Increasing Its Dividend To ₹25.00

Jan 27
Torrent Pharmaceuticals (NSE:TORNTPHARM) Is Increasing Its Dividend To ₹25.00

Here's Why Torrent Pharmaceuticals (NSE:TORNTPHARM) Can Manage Its Debt Responsibly

Jan 04
Here's Why Torrent Pharmaceuticals (NSE:TORNTPHARM) Can Manage Its Debt Responsibly

Here's Why I Think Torrent Pharmaceuticals (NSE:TORNTPHARM) Is An Interesting Stock

Dec 14
Here's Why I Think Torrent Pharmaceuticals (NSE:TORNTPHARM) Is An Interesting Stock

A Look At The Fair Value Of Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)

Nov 07
A Look At The Fair Value Of Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)

Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly

Sep 30
Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly

Does Torrent Pharmaceuticals (NSE:TORNTPHARM) Deserve A Spot On Your Watchlist?

Sep 01
Does Torrent Pharmaceuticals (NSE:TORNTPHARM) Deserve A Spot On Your Watchlist?

Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly

Jul 02
Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly

I Ran A Stock Scan For Earnings Growth And Torrent Pharmaceuticals (NSE:TORNTPHARM) Passed With Ease

Jun 01
I Ran A Stock Scan For Earnings Growth And Torrent Pharmaceuticals (NSE:TORNTPHARM) Passed With Ease

Torrent Pharmaceuticals Limited (NSE:TORNTPHARM) Shares Could Be 30% Above Their Intrinsic Value Estimate

May 14
Torrent Pharmaceuticals Limited (NSE:TORNTPHARM) Shares Could Be 30% Above Their Intrinsic Value Estimate

Does Torrent Pharmaceuticals (NSE:TORNTPHARM) Have A Healthy Balance Sheet?

Mar 23
Does Torrent Pharmaceuticals (NSE:TORNTPHARM) Have A Healthy Balance Sheet?

The Torrent Pharmaceuticals (NSE:TORNTPHARM) Share Price Has Gained 84% And Shareholders Are Hoping For More

Mar 02
The Torrent Pharmaceuticals (NSE:TORNTPHARM) Share Price Has Gained 84% And Shareholders Are Hoping For More

Is It Smart To Buy Torrent Pharmaceuticals Limited (NSE:TORNTPHARM) Before It Goes Ex-Dividend?

Feb 10
Is It Smart To Buy Torrent Pharmaceuticals Limited (NSE:TORNTPHARM) Before It Goes Ex-Dividend?

Do Torrent Pharmaceuticals's (NSE:TORNTPHARM) Earnings Warrant Your Attention?

Jan 19
Do Torrent Pharmaceuticals's (NSE:TORNTPHARM) Earnings Warrant Your Attention?

Should You Be Impressed By Torrent Pharmaceuticals Limited's (NSE:TORNTPHARM) ROE?

Dec 29
Should You Be Impressed By Torrent Pharmaceuticals Limited's (NSE:TORNTPHARM) ROE?

Is Torrent Pharmaceuticals (NSE:TORNTPHARM) Using Too Much Debt?

Dec 08
Is Torrent Pharmaceuticals (NSE:TORNTPHARM) Using Too Much Debt?

Investors Who Bought Torrent Pharmaceuticals (NSE:TORNTPHARM) Shares Three Years Ago Are Now Up 118%

Nov 16
Investors Who Bought Torrent Pharmaceuticals (NSE:TORNTPHARM) Shares Three Years Ago Are Now Up 118%

The Torrent Pharmaceuticals Limited (NSE:TORNTPHARM) Second-Quarter Results Are Out And Analysts Have Published New Forecasts

Oct 28
The Torrent Pharmaceuticals Limited (NSE:TORNTPHARM) Second-Quarter Results Are Out And Analysts Have Published New Forecasts

配当金の支払いについて

今日Jun 19 2024配当落ち日Jun 21 20240次の2 days 、次の配当を受け取るために購入する。0

決済の安定と成長

配当データの取得

安定した配当: TORNTPHARMの配当金支払いは、過去10年間 変動性 が高かった。

増加する配当: TORNTPHARMの配当金は過去10年間にわたって増加しています。


配当利回り対市場

Torrent Pharmaceuticals 配当利回り対市場
TORNTPHARM 配当利回りは市場と比べてどうか?
セグメント配当利回り
会社 (TORNTPHARM)1.0%
市場下位25% (IN)0.3%
市場トップ25% (IN)1.1%
業界平均 (Pharmaceuticals)0.8%
3年後のアナリスト予想 (TORNTPHARM)1.2%

注目すべき配当: TORNTPHARMの配当金 ( 0.97% ) はIndian市場の配当金支払者の下位 25% ( 0.27% ) よりも高くなっています。

高配当: TORNTPHARMの配当金 ( 0.97% ) はIndian市場の配当金支払者の上位 25% ( 1.16% ) と比較すると低いです。


株主への利益配当

収益カバレッジ: TORNTPHARMの配当金は、合理的な 配当性向 ( 57.2% ) により、利益によって賄われています。


株主配当金

キャッシュフローカバレッジ: TORNTPHARMの 現金配当性向 ( 33.5% ) は比較的低く、配当金の支払いはキャッシュフローによって十分にカバーされています。


高配当企業の発掘